Billing and Coding: Infliximab

This billing and coding article provides supplemental guidance for infliximab and explicitly complements Local Coverage Determination L35677. Coverage, medical necessity criteria, and required documentation for infliximab are determined by LCD L35677, so providers should refer to that LCD for specific indications, limitations, and claim requirements.

"Providers must follow the Local Coverage Determination (LCD) L35677 for clinical indications, coverage decisions, and documentation requirements for infliximab."

Sign up to see full coverage criteria, indications, and limitations.